News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
650,621 Results
Type
Article (40656)
Company Profile (217)
Press Release (609748)
Section
Business (186794)
Career Advice (2797)
Deals (34484)
Drug Delivery (100)
Drug Development (77328)
Employer Resources (165)
FDA (16052)
Job Trends (15272)
News (323076)
Policy (31286)
Tag
Academia (2679)
Alliances (46317)
Alzheimer's disease (1308)
Approvals (15999)
Artificial intelligence (158)
Bankruptcy (310)
Best Places to Work (12154)
Biotechnology (124)
Breast cancer (187)
Cancer (1349)
Cardiovascular disease (114)
Career advice (2328)
Cell therapy (295)
Clinical research (61908)
Collaboration (492)
Compensation (259)
COVID-19 (2511)
C-suite (116)
Data (1418)
Diabetes (169)
Diagnostics (6467)
Earnings (72887)
Employer resources (145)
Events (106399)
Executive appointments (409)
FDA (16729)
Funding (426)
Gene therapy (200)
GLP-1 (574)
Government (4179)
Healthcare (19850)
Infectious disease (2597)
Inflammatory bowel disease (120)
Interviews (538)
IPO (16395)
Job creations (3556)
Job search strategy (1943)
Layoffs (417)
Legal (7262)
Lung cancer (189)
Manufacturing (214)
Medical device (13904)
Medtech (13909)
Mergers & acquisitions (18302)
Metabolic disorders (425)
Neuroscience (1637)
NextGen Class of 2024 (6878)
Non-profit (4831)
Northern California (1725)
Obesity (230)
Opinion (226)
Parkinson's disease (98)
Patents (119)
People (54572)
Phase I (19123)
Phase II (27447)
Phase III (20531)
Pipeline (509)
Postmarket research (2253)
Preclinical (7984)
Radiopharmaceuticals (248)
Rare diseases (279)
Real estate (5455)
Regulatory (21282)
Research institute (2463)
Resumes & cover letters (453)
Southern California (1491)
Startups (3315)
United States (15485)
Vaccines (525)
Weight loss (155)
Date
Last 7 days (612)
Last 30 days (2374)
Last 365 days (36384)
2024 (36217)
2023 (41626)
2022 (52750)
2021 (57490)
2020 (56085)
2019 (49298)
2018 (37210)
2017 (33230)
2016 (31943)
2015 (37257)
2014 (27816)
2013 (22487)
2012 (23935)
2011 (24646)
2010 (21844)
Location
Africa (827)
Arizona (136)
Asia (39261)
Australia (6698)
California (3845)
Canada (1452)
China (307)
Colorado (176)
Connecticut (191)
Europe (87246)
Florida (544)
Georgia (144)
Illinois (401)
Indiana (232)
Maryland (622)
Massachusetts (3078)
Michigan (191)
Minnesota (293)
New Jersey (1115)
New York (1088)
North Carolina (801)
Northern California (1725)
Ohio (150)
Pennsylvania (934)
South America (1186)
Southern California (1491)
Texas (558)
Utah (116)
Washington State (408)
650,621 Results for "index pharmaceuticals ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Conduit Pharmaceuticals to Join Russell 3000® Index
Conduit Pharmaceuticals Inc., announced the Company is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024, according to a preliminary list of additions posted by FTSE Russell on Friday, May 24th, 2024.
June 13, 2024
·
5 min read
Avadel Pharmaceuticals to Join Russell 3000® Index - June 27, 2024
Avadel Pharmaceuticals plc announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024, according to a preliminary list of additions posted Friday, May 24, 2024.
June 27, 2024
·
3 min read
InDex Pharmaceuticals announces expected cash balance per March 31, 2024
InDex Pharmaceuticals Holding AB announced that remaining commitments for the company have been quantified, and the expected cash balance per March 31, 2024, amounts to SEK 180-190 million.
January 19, 2024
·
2 min read
Press Releases
Altimmune Added to Nasdaq Biotechnology Index
December 19, 2024
·
2 min read
Press Releases
Mesoblast to be Added to Nasdaq Biotechnology Index
December 19, 2024
·
5 min read
Press Releases
MindMed to Be Added to the Nasdaq Biotechnology Index
December 19, 2024
·
4 min read
Press Releases
CorMedix Inc. Added to Nasdaq Biotechnology Index
December 20, 2024
·
1 min read
ChromaDex to Join Russell 2000® Index
ChromaDex Corp., the global authority on nicotinamide adenine dinucleotide research with a focus on healthy aging, announced its inclusion in the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes.
July 1, 2024
·
6 min read
Press Releases
Spyre Therapeutics Added to the Nasdaq Biotechnology Index
December 19, 2024
·
1 min read
Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes
Invivyd, Inc., a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, announced that as part of the annual reconstitution of the Russell stock indexes, Invivyd will be included in the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the open of U.S. equity markets.
July 1, 2024
·
1 min read
1 of 65,063
Next
